Literature DB >> 20978763

Experiment on enhancing antitumor effect of intravenous epirubicin hydrochloride by acoustic cavitation in situ combined with phospholipid-based microbubbles.

Cui-Tao Lu1, Ying-Zheng Zhao, Yan Wu, Xin-Qiao Tian, Wen-Feng Li, Pin-Tong Huang, Xiao-Kun Li, Chang-Zheng Sun, Lu Zhang.   

Abstract

OBJECTIVE: An in vivo study on enhancing antitumor effect of intravenous epirubicin hydrochloride (EPI) by acoustic cavitation in situ combined with phospholipid-based microbubbles (PMB) was reported.
METHODS: Five-week-old male nude mice were used, and HCT-116 cells were s.c. (subcutaneous injection) inoculated in axilla of these mice. Five groups were designed and five consecutive treatments were applied to investigate the tumor growth, body weight growth, and normal organ growth.
RESULTS: Inhibition effects on tumor growth were observed in all groups treated by EPI. However, the potency of tumor growth retardation caused by EPI depended on the application of PMB and US in situ. An effective retardation on tumor growth and improved mice survival status were observed when intravenous EPI combined with sonicated PMB in situ. Short-term lingering sensitive period for chemotherapeutic drugs after acoustic cavitation was also observed in experiment under asynchronous administration of EPI and sonicated PMB.
CONCLUSION: Intravenous EPI combined with PMB-mediated cavitation in situ might provide a potential application for US-mediated chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978763     DOI: 10.1007/s00280-010-1489-4

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

Review 1.  A review of low-intensity ultrasound for cancer therapy.

Authors:  Andrew K W Wood; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2015-04       Impact factor: 2.998

2.  An experimental research into endostatin microbubble combined with focused ultrasound for anti-tumor angiogenesis in colon cancer.

Authors:  Xiufeng Zhang; Guangen Yang; Ying Zhang; Pintong Huang; Jianming Qiu; Yu Sun; Zhong Shen; Xiujun Liao; Hongsheng Xia; Shuxian Shao; Dong Wang
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-01-28

3.  Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo.

Authors:  Inoru Yokoe; Daiki Omata; Johan Unga; Ryo Suzuki; Kazuo Maruyama; Yoshiharu Okamoto; Tomohiro Osaki
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 4.  Potential and problems in ultrasound-responsive drug delivery systems.

Authors:  Ying-Zheng Zhao; Li-Na Du; Cui-Tao Lu; Yi-Guang Jin; Shu-Ping Ge
Journal:  Int J Nanomedicine       Date:  2013-04-22

Review 5.  Sonochemotherapy: from bench to bedside.

Authors:  Bart H A Lammertink; Clemens Bos; Roel Deckers; Gert Storm; Chrit T W Moonen; Jean-Michel Escoffre
Journal:  Front Pharmacol       Date:  2015-07-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.